AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimibose MV 2mg/500mg/0.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

B.J.Healthcare

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glimibose MV 2mg/500mg/0.2mg Tablet SR

This medication, Glimibose MV 2mg/500mg/0.2mg Tablet SR, is an antidiabetic combination drug used to manage type 2 diabetes in adults. It helps regulate blood glucose levels. Take this extended-release tablet with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is vital; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. This medicine is just one component of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize its symptoms—sweating, dizziness, headache, trembling—and how to manage them. Regular meals and readily available glucose sources (e.g., sugary foods or juice) are crucial. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, upper respiratory infections, and weight gain. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Glimibose MV 2mg/500mg/0.2mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimibose MV 2mg/500mg/0.2mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimibose MV 2mg/500mg/0.2mg Tablet SR whole; do not break, crush, or chew it. Administer on an empty stomach.

Common Side effects of Glimibose MV 2mg/500mg/0.2mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimibose MV 2mg/500mg/0.2mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimibose MV 2mg/500mg/0.2mg Tablet SR whole; do not damage or alter its form in any way. Administer on an empty stomach.

How Glimibose MV 2mg/500mg/0.2mg Tablet SR works:

A single tablet of Glibenclamide/Metformin/Pioglitazone extended-release (2mg/500mg/0.2mg) combines three agents to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimibose MV 2mg/500mg/0.2mg Tablet SR with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimibose MV 2mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before using this medicine.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Glimibose MV tablets (2mg/500mg/0.2mg) are likely unsuitable for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk with possible infant harm.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

The use of Glimibose MV 2mg/500mg/0.2mg sustained-release tablets carries a high risk in individuals with kidney impairment and should be omitted. Patients with this condition should seek medical advice before considering this medication. Furthermore, its administration is contraindicated in those experiencing severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Glimibose MV 2mg/500mg/0.2mg SR tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. For those with mild to moderate liver disease, a low initial dose is typically recommended; however, its use is contraindicated in patients with severe liver dysfunction.

What if you forget to take Glimibose MV 2mg/500mg/0.2mg Tablet SR :

Should you forget to take your Glimibose MV 2mg/500mg/0.2mg Tablet SR, administer the dose immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Glimibose MV 2mg/500mg/0.2mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimibose MV 2mg/500mg/0.2mg Tablet SR

Glimibose MV 2mg/500mg/0.2mg Sustained-Release tablets contain glimepiride, metformin, and voglibose. This triple-drug therapy manages type 2 diabetes mellitus in adults, enhancing glycemic control when combined with a healthy diet and exercise regimen. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin decreases hepatic glucose production and enhances insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal blood sugar elevation. This formulation is unsuitable for type 1 diabetes.
Glimibose MV 2mg/500mg/0.2mg SR tablets may cause common adverse reactions including low blood glucose, gastrointestinal upset (such as nausea, diarrhea, and flatulence), altered taste perception, abdominal pain, headache, skin eruptions, and respiratory illnesses.
Patients with hypersensitivity to any ingredient or inactive component of Glimibose MV 2mg/500mg/0.2mg Tablet SR should not take this medication. Its use is contraindicated in individuals with moderate to severe renal impairment, as well as those with inflammatory bowel disease, colonic ulcers, and underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Glimibose MV 2mg/500mg/0.2mg SR tablets with alcohol is unsafe. This combination can dangerously reduce blood sugar (causing hypoglycemia) and heighten the risk of lactic acidosis.
Indeed, Glimibose MV 2mg/500mg/0.2mg SR tablets can induce hypoglycemia. Low blood sugar manifests as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Retain this medication within its original, sealed packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Glimibose MV 2mg/500mg/0....
82
MRP 100
17% off